Recon: FDA lifts hold on bluebird bio’s sickle cell gene therapy; AstraZeneca wins EU approval for heart failure drug
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy